United States Halts AstraZeneca Vaccine Production at Baltimore Plant

© Reuters.

© Reuters. FILE PHOTO: Vial with AstraZeneca’s coronavirus disease (COVID-19) vaccine in Berlin

(Reuters) – The administration of US President Joe Biden on Saturday halted a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s (NYSE 🙂 COVID-19 vaccine to make another vaccine developed by AstraZeneca (NASDAQ :), the New York Times reported on Saturday. Management has put Johnson & Johnson in charge of the troubled manufacturing plant, according to the report. The extraordinary step by U.S. Health and Human Services will have the Emergent BioSolutions facility dedicated exclusively to manufacturing Johnson & Johnson’s single-dose vaccine, and is intended to prevent future confusion, according to the report, which cites two top federal health officials. Johnson & Johnson said it was “assuming full responsibility,” confirming the changes, the report added.

Disclaimer: Fusion Media wishes to remind you that the data contained on this website is not necessarily accurate or in real time. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of the use of this data. Fusion Media or anyone involved with Fusion Media will accept no responsibility for loss or damage as a result of reliance on information, including data, quotes, charts, and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading the financial markets, it is one of the riskiest forms of investment possible.